Nav: Home

Well-known molecule not found in cancer cells after all

September 24, 2020

A new research result from Aarhus University shows that a so-called circular RNA molecule, which has been designated as carcinogenic, is actually not found in the cancer cells. The results have just been published in Nature Communications.

In a major surprise, researchers from Aarhus University have discovered that an otherwise extensively studied carcinogenic RNA molecule is not found in the cancerous cells at all. Instead, they suggest that the molecule contributes to the cancer developing through what is known as the microenvironment which constitutes the cancerous cells' 'neighbourhood', i.e. the cells which lie in the environment around the cancer cells in a tumour.

RNA molecules are normally linear and help to ensure that the right proteins are formed in the cells.

"Now we know that certain RNA molecules can, popularly speaking, also bite their own tails and form closed rings, and this gives them completely new properties in the cells," says Lasse Sommer Kristensen from Aarhus University, who is behind the study.

The circular RNA molecule studied by the researchers is called ciRS-7.

Checking the neighbourhood

According to Lasse Sommer Kristensen, an important step in understanding the carcinogenic properties of molecules is to map where these molecules are located in the tumour and which types of cell they are found in.

He predicts that these new results will move the research field in a completely new direction and increase focus on understanding how the molecules work through the microenvironment of the cancer cells.

"We've recently witnessed an explosion of research activity within this new research area, but with our study we show that the conclusions reached by many of the first studies of ciRS-7 are probably premature, primarily due to a lack of spatial analyses," says the researcher.

"We see that other benign cell types in a tumour express very high levels of CiRS-7, which means that the molecule may instead contribute to cancer development through the microenvironment."

More spatial analyses

According to the researchers, when trying to understand the molecular mechanisms that contribute to the development of cancer, it is important to look at cancer as a complex interaction between the cancer cells and the many other types of benign cell types which are found in a tumour.

"In other words, the classic cancer cell lines that are grown in the laboratory and often used to try and understand new molecular mechanisms, don't always give us an accurate view of what is in play in an actual tumour," says Lasse Sommer Kristensen.

He emphasises that the results are therefore a good example of how spatial analyses of patient tumours can contribute with important knowledge that would not have been gained by analysing all RNA from a tumour in a single analysis.

The researchers are now continuing their work towards understanding why ciRS-7 is expressed at a very high level in the tumour's benign cells and whether this molecule contributes directly to the development of cancer through the microenvironment.
-end-
Background for the results

Basic research

The study is financed by the Lundbeck Foundation, the Independent Research Fund Denmark and the Villum Foundation.

The study was conducted in collaboration with Henrik Hager from the Hospital Lillebaelt, Vejle and Jørgen Kjems from the Department of Molecular Biology and Genetics, Aarhus University.

The scientific article can be read in Nature Communications: https://www.nature.com/articles/s41467-020-18355-2

PhD Lasse Sommer Kristensen
Aarhus University, Department of Biomedicine
Mobile: (+45) 2888 0562
Twitter: @Kristensen_Lab
Email: lasse@biomed.au.dk

Aarhus University

Related Cancer Articles:

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.
Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.
Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.
Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.
Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.
Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.
More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.
New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.
American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.
Oncotarget: Cancer pioneer employs physics to approach cancer in last research article
In the cover article of Tuesday's issue of Oncotarget, James Frost, MD, PhD, Kenneth Pienta, MD, and the late Donald Coffey, Ph.D., use a theory of physical and biophysical symmetry to derive a new conceptualization of cancer.
More Cancer News and Cancer Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: The Power Of Spaces
How do spaces shape the human experience? In what ways do our rooms, homes, and buildings give us meaning and purpose? This hour, TED speakers explore the power of the spaces we make and inhabit. Guests include architect Michael Murphy, musician David Byrne, artist Es Devlin, and architect Siamak Hariri.
Now Playing: Science for the People

#576 Science Communication in Creative Places
When you think of science communication, you might think of TED talks or museum talks or video talks, or... people giving lectures. It's a lot of people talking. But there's more to sci comm than that. This week host Bethany Brookshire talks to three people who have looked at science communication in places you might not expect it. We'll speak with Mauna Dasari, a graduate student at Notre Dame, about making mammals into a March Madness match. We'll talk with Sarah Garner, director of the Pathologists Assistant Program at Tulane University School of Medicine, who takes pathology instruction out of...
Now Playing: Radiolab

What If?
There's plenty of speculation about what Donald Trump might do in the wake of the election. Would he dispute the results if he loses? Would he simply refuse to leave office, or even try to use the military to maintain control? Last summer, Rosa Brooks got together a team of experts and political operatives from both sides of the aisle to ask a slightly different question. Rather than arguing about whether he'd do those things, they dug into what exactly would happen if he did. Part war game part choose your own adventure, Rosa's Transition Integrity Project doesn't give us any predictions, and it isn't a referendum on Trump. Instead, it's a deeply illuminating stress test on our laws, our institutions, and on the commitment to democracy written into the constitution. This episode was reported by Bethel Habte, with help from Tracie Hunte, and produced by Bethel Habte. Jeremy Bloom provided original music. Support Radiolab by becoming a member today at Radiolab.org/donate.     You can read The Transition Integrity Project's report here.